Learn More
Fisher Healthcare™ Sure-Vue™ RPR Antigen Suspension

Sure-Vue’s non-treponemal RPR antigen screens for syphilis; a sexually transmitted disease caused by the bacterium Treponema pallidum (a spirochete bacteria). The disease is found worldwide and is easily treated if detected early. This test is FDA cleared for use in diagnostic screening.
Description
- CLIA Complexity: Non-Waived
- CPT Codes: 86542/86593
- Cardiolipin charcoal microparticle test for the qualitative and semi-quantitative determination of reagin, which is associated with syphilis
- Antigen detects 'reagin' present in serum of syphilitic patients
- Test results in eight minutes
- Positive results yield a flocculation of the antigen; negative results yield no reaction and a gray homogeneous suspension, or a button of non-aggregating carbon particles in the center of the circle
- For in vitro diagnostic use
- Contains Sodium Azide 0.1%
Specifications
RPR Antigen Suspension | |
Moderate (Serum, Plasma or Whole Blood), Waived (Other) | |
RPR Antigen Suspension | |
For in-vitro diagnostic use | |
Ready-to-Use (RTU) |
Self-declared | |
Reagin (Syphilis) | |
Single-use | |
1 x 9 mL |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.